Concord Repatriation General Hospital, commonly referred to as Concord Hospital, is a major hospital in Sydney, Australia, on Hospital Road in Concord.

There are 500 beds in Concord Repatriation General Hospital; Haematology.

During the past decade, Concord Repatriation General Hospital; Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Concord Repatriation General Hospital; Haematology" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Concord Repatriation General Hospital; Haematology" are "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma, Lymphoma Follicular" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Concord Repatriation General Hospital; Haematology" in a lesser frequency.

Most popular intervention types in "Concord Repatriation General Hospital; Haematology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Doxorubicin" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Concord Repatriation General Hospital; Haematology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Concord Repatriation General Hospital; Haematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Concord Repatriation General Hospital; Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Concord Repatriation General Hospital; Haematology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".